Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 5 minute read General business news Will Polyrizon’s $5.8m move into private aviation reshape its biotech-focused capital strategy? (NASDAQ: PLRZ) Polyrizon plans to buy 51% of Arrow Aviation in a $5.8M deal. Find out how this biotech-to-aviation pivot could reshape its capital strategy. bySoujanya RaviFebruary 5, 2026